In the group of patients hospitalized for a first acute NSTEMI, without reduced LVEF, and with high galectin-3 plasma levels, there were significantly more patients with AF (70.7%), compared with the group with low galectin-3 plasma levels (23.1%, p < 0.01). The gene discussed is LGALS3; the disease is atrial fibrillation.